HST
49
-9
CINF
53
2
AA
48
-12
CMA
61
5
PVH
62
5
MHK
49
4
CFG
70
6
LNC
39
3
PSA
58
2
URBN
56
14
CL
58
2
USB
55
-6
SE
61
-4
EBAY
47
4
URI
65
5
XRX
44
3
APD
59
2
PFG
45
3
BSX
67
-3
PLD
56
8
HST
49
-9
CINF
53
2
AA
48
-12
CMA
61
5
PVH
62
5
MHK
49
4
CFG
70
6
LNC
39
3
PSA
58
2
URBN
56
14
CL
58
2
USB
55
-6
SE
61
-4
EBAY
47
4
URI
65
5
XRX
44
3
APD
59
2
PFG
45
3
BSX
67
-3
PLD
56
8
Financhill
Back

Novo Nordisk AS Vs. Ascendis Pharma AS Industry Stock Comparison

Sell
40

NVO
Novo Nordisk AS

Last Price:
105.10
Seasonality Move:
10.2%
Sell
27

ASND
Ascendis Pharma AS

Last Price:
130.01
Seasonality Move:
20.86%
Sell
40
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $105.06. The Score for NVO is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
27
Ascendis Pharma AS (ASND) is a Sell

Is Ascendis Pharma AS a Buy, Sell or Hold?

  • The current Ascendis Pharma AS [ASND] share price is $129.81. The Score for ASND is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • ASND is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $105.06
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

ASND Stock Price Chart

What is Ascendis Pharma AS's stock price today?

  • The Ascendis Pharma AS share price today is $129.81
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ASND is experiencing buying pressure, which is a positive indicator for future bullish movement.

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -3.67 Sell
Relative Strength Index (14 RSI): 41.39 Sell
Chaikin Money Flow: 49323 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (104.22 - 113.68) Sell
Bollinger Bands (100): (113.16 - 136.4) Sell

ASND Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -1.53 Sell
Relative Strength Index (14 RSI): 53.83 Buy
Chaikin Money Flow: 334016 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (124.01 - 129.03) Buy
Bollinger Bands (100): (124.29 - 141.45) Sell

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 103.67 Buy
20-day SMA: 107.35 Sell
50-day SMA: 115.47 Sell
200-day SMA: 127.84 Sell
8-day EMA: 104.35 Buy
20-day EMA: 107.36 Sell
50-day EMA: 114.34 Sell
200-day EMA: 120.49 Sell

ASND Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 125.01 Buy
20-day SMA: 125.87 Buy
50-day SMA: 133.06 Sell
200-day SMA: 136.78 Sell
8-day EMA: 125.66 Buy
20-day EMA: 126.61 Buy
50-day EMA: 129.57 Buy
200-day EMA: 130.24 Sell

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and an increase next year of $0.74 per share.

Ascendis Pharma AS Earnings Growth & ASND Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.89 per share, and an increase next year of $4.01 per share.

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Ascendis Pharma AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):